GINA MARIE MONTANARI: Open Payments
NPI 1851028914 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 53 payments from 9 companies in 2025. Trend: 2023 $1,681 · 2024 $1,598 · 2025 $881
Food & beverage: $872Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $226 |
| ABBVIE INC. | 17 | $217 |
| UCB, Inc. | 12 | $138 |
| Amgen Inc. | 3 | $70 |
| GENZYME CORPORATION | 2 | $66 |
| Lilly USA, LLC | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Organon LLC | 2 | $37 |
| Incyte Corporation | 1 | $19 |
Products named: COSENTYX, Bimzelx, SKYRIZI, RINVOQ, OTEZLA, DUPIXENT, TALTZ, Sotyktu.
Industry payments across NY — which companies pay providers there.
